FindTrial
Sign In

The role of lncRNA in Exosomes in Hepatocellular Carcinoma

The role of lncRNA in Exosomes in Hepatocellular Carcinoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800015941
Enrollment
Unknown
Registered
2018-05-01
Start date
2018-06-01
Completion date
Unknown
Last updated
2019-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular Carcinoma

Interventions

Case series:none

Sponsors

Guangzhou First People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients diagnosed as hepatocellular Carcinoma and received tumor resection in our hospital from May 2017 to April 2023 with complete information.

Exclusion criteria

Exclusion criteria: 1. Patients with serious cardiovascular, lung, kidney, immune and hematological diseases and cerebrovascular disease; 2. Patients with severe acute infections or those with psychiatry issues; 3. Patients who refused to consent to this study.

Design outcomes

Primary

MeasureTime frame
Exosome;Long noncoding RNA(lncRNA);Apoptosis-related indicators;Proliferation Related indexes;Inflammation related factors;—

Countries

China

Contacts

Public ContactLu MinQiang

Guangzhou First People's Hospital

larrylmq@outlook.com+86 13802747201

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026